{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:24:29Z","timestamp":1792250669357,"version":"4.4.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["#19-74-30007"],"award-info":[{"award-number":["#19-74-30007"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Alzheimer\u2019s disease (AD) is a multifactorial systemic disease that is triggered, at least in part, by the accumulation of \u03b2-amyloid (A\u03b2) peptides in the brain, but it also depends on immune system-mediated regulation. Recent studies suggest that B cells may play a role in AD development and point to the accumulation of clonally expanded B cells in AD patients. However, the specificity of the clonally expanded B cells is unknown, and the contribution of A\u03b2-specific B cells to AD pathology development is unclear. In this study, we have developed a novel method to identify A\u03b2-specific B cells by flow cytometry using fluorescent tetramers. The suggested method also enables the identification of B-cell clones specific to a more pathology-provoking form of A\u03b2 with an isomerized Asp7 residue (Iso-D7-A\u03b2) that accumulates in elderly people and in AD patients. The method has been verified using mice immunized with antigens containing the isomerized or non-isomerized A\u03b2 N-terminus peptides. In addition, we describe a new method for the detection of Iso-D7-A\u03b2-specific antibodies, which was tested on mouse serum. These methods are of potential importance in research aimed at studying AD and may be also utilized for diagnostic and therapeutic purposes.<\/jats:p>","DOI":"10.1093\/biomethods\/bpaf001","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T07:34:59Z","timestamp":1736235299000},"source":"Crossref","is-referenced-by-count":2,"title":["Novel method for detection of A\u03b2 and Iso-D7-A\u03b2 N-terminus-specific B cells and Iso-D7-A\u03b2-specific antibodies"],"prefix":"10.1093","volume":"10","author":[{"given":"Elizaveta A","family":"Kolobova","sequence":"first","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences , 119991, Moscow,","place":["Russia"]},{"name":"Institute of Translational Medicine, Department of Molecular Technologies, Pirogov Russian National Research Medical University , 117513, Moscow,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina Yu","family":"Petrushanko","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences , 119991, Moscow,","place":["Russia"]},{"name":"Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences , 119991, Moscow,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir A","family":"Mitkevich","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences , 119991, Moscow,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A","family":"Makarov","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences , 119991, Moscow,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4963-7403","authenticated-orcid":false,"given":"Irina L","family":"Grigorova","sequence":"additional","affiliation":[{"name":"Engelhardt Institute of Molecular Biology, Russian Academy of Sciences , 119991, Moscow,","place":["Russia"]},{"name":"Institute of Translational Medicine, Department of Molecular Technologies, Pirogov Russian National Research Medical University , 117513, Moscow,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"2025030711374312200_bpaf001-B1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2174\/1567205014666170417111859","article-title":"Tau in Alzheimer\u2019s disease: mechanisms and therapeutic strategies","volume":"15","author":"Gao","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"2025030711374312200_bpaf001-B2","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The Amyloid-\u03b2 pathway in Alzheimer\u2019s disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol Psychiatry"},{"key":"2025030711374312200_bpaf001-B3","doi-asserted-by":"crossref","first-page":"a011585","DOI":"10.1101\/cshperspect.a011585","article-title":"Alzheimer disease in 2020","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2025030711374312200_bpaf001-B4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The role of Tau in Alzheimer\u2019s disease and related disorders","volume":"17","author":"Medeiros","year":"2011","journal-title":"CNS Neurosci Ther"},{"key":"2025030711374312200_bpaf001-B5","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer\u2019s disease: the prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"2025030711374312200_bpaf001-B6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","article-title":"The complexity of tau in Alzheimer\u2019s disease","volume":"705","author":"Naseri","year":"2019","journal-title":"Neurosci Lett"},{"key":"2025030711374312200_bpaf001-B7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"2025030711374312200_bpaf001-B8","doi-asserted-by":"crossref","first-page":"105196","DOI":"10.1016\/j.jbc.2023.105196","article-title":"Modulation of aggregation and structural polymorphisms of \u03b2-amyloid fibrils in cellular environments by pyroglutamate-3 variant cross-seeding","volume":"299","author":"Cruceta","year":"2023","journal-title":"J Biol Chem"},{"key":"2025030711374312200_bpaf001-B9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00401-013-1107-8","article-title":"Early intraneuronal accumulation and increased aggregation of phosphorylated Abeta in a mouse model of Alzheimer\u2019s disease","volume":"125","author":"Kumar","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2025030711374312200_bpaf001-B10","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/emboj.2011.138","article-title":"Extracellular phosphorylation of the amyloid \u03b2-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer\u2019s disease","volume":"30","author":"Kumar","year":"2011","journal-title":"Embo J"},{"key":"2025030711374312200_bpaf001-B11","doi-asserted-by":"crossref","first-page":"e2210766119","DOI":"10.1073\/pnas.2210766119","article-title":"Early diagnosis and treatment of Alzheimer\u2019s disease by targeting toxic soluble A\u03b2 oligomers","volume":"119","author":"Habashi","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025030711374312200_bpaf001-B12","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.3390\/ijms22126355","article-title":"Neurotoxic soluble amyloid oligomers drive Alzheimer\u2019s pathogenesis and represent a clinically validated target for slowing disease progression","volume":"22","author":"Tolar","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025030711374312200_bpaf001-B13","doi-asserted-by":"crossref","first-page":"e202215785","DOI":"10.1002\/anie.202215785","article-title":"Imaging Amyloid-\u03b2 membrane interactions: ion-channel pores and lipid-bilayer permeability in Alzheimer\u2019s disease","volume":"62","author":"Viles","year":"2023","journal-title":"Angew Chem Int Ed Engl"},{"key":"2025030711374312200_bpaf001-B14","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1134\/S0026893316050034","article-title":"Isomerization of Asp7 increases the toxic effects of amyloid \u03b2 and its phosphorylated form in SH-SY5Y neuroblastoma cells","volume":"50","author":"Barykin","year":"2016","journal-title":"Mol Biol (Mosk)"},{"key":"2025030711374312200_bpaf001-B15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bpj.2011.11.4006","article-title":"NMR solution structure of rat a\u03b2(1-16): toward understanding the mechanism of rats\u2019 resistance to Alzheimer\u2019s disease","volume":"102","author":"Istrate","year":"2012","journal-title":"Biophys J"},{"key":"2025030711374312200_bpaf001-B16","doi-asserted-by":"crossref","first-page":"e939\u2013e939","DOI":"10.1038\/cddis.2013.492","article-title":"Isomerization of Asp7 leads to increased toxic effect of amyloid-\u03b242 on human neuronal cells","volume":"4","author":"Mitkevich","year":"2013","journal-title":"Cell Death Dis"},{"key":"2025030711374312200_bpaf001-B17","doi-asserted-by":"crossref","first-page":"L84","DOI":"10.1016\/j.bpj.2010.09.015","article-title":"Minimal Zn(2+) binding site of amyloid-\u03b2","volume":"99","author":"Tsvetkov","year":"2010","journal-title":"Biophys J"},{"key":"2025030711374312200_bpaf001-B18","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/brainsci14101042","article-title":"Beta-Amyloid and its Asp7 isoform: morphological and aggregation properties and effects of intracerebroventricular administration","volume":"14","author":"Ushakova","year":"2024","journal-title":"Brain Sci"},{"key":"2025030711374312200_bpaf001-B19","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12640-013-9399-y","article-title":"Peripherally applied synthetic peptide isoAsp7-A\u03b2(1-42) triggers cerebral \u03b2-amyloidosis","volume":"24","author":"Kozin","year":"2013","journal-title":"Neurotox Res"},{"key":"2025030711374312200_bpaf001-B20","first-page":"309","article-title":"Zn-dependent \u03b2-amyloid Aggregation and its reversal by the tetrapeptide HAEE","volume":"14","author":"Mitkevich","year":"2023","journal-title":"Aging Dis"},{"key":"2025030711374312200_bpaf001-B21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40478-017-0505-x","article-title":"Pyroglutamate and isoaspartate modified amyloid-beta in ageing and Alzheimer\u2019s disease","volume":"6","author":"Moro","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"2025030711374312200_bpaf001-B22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbi.2022.11.012","article-title":"B lymphocytes ameliorate Alzheimer\u2019s disease-like neuropathology via interleukin-35","volume":"108","author":"Feng","year":"2023","journal-title":"Brain Behav Immun"},{"key":"2025030711374312200_bpaf001-B23","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/s41467-021-22479-4","article-title":"Therapeutic B-cell depletion reverses progression of Alzheimer\u2019s disease","volume":"12","author":"Kim","year":"2021","journal-title":"Nat Commun"},{"key":"2025030711374312200_bpaf001-B24","doi-asserted-by":"crossref","first-page":"eabb0457","DOI":"10.1126\/sciadv.abb0457","article-title":"Association of naturally occurring antibodies to \u03b2-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer\u2019s disease","volume":"7","author":"Liu","year":"2021","journal-title":"Sci Adv"},{"key":"2025030711374312200_bpaf001-B25","doi-asserted-by":"crossref","first-page":"111391","DOI":"10.1016\/j.celrep.2022.111391","article-title":"Association of B cell profile and receptor repertoire with the progression of Alzheimer\u2019s disease","volume":"40","author":"Park","year":"2022","journal-title":"Cell Rep"},{"key":"2025030711374312200_bpaf001-B26","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.3390\/cells13191624","article-title":"\u03b2-Amyloids and Immune Responses Associated with Alzheimer\u2019s Disease","volume":"13","author":"Kolobova","year":"2024","journal-title":"Cells"}],"container-title":["Biology Methods and Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomethods\/advance-article-pdf\/doi\/10.1093\/biomethods\/bpaf001\/61362636\/bpaf001.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/10\/1\/bpaf001\/61362636\/bpaf001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/10\/1\/bpaf001\/61362636\/bpaf001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:38:04Z","timestamp":1741347484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomethods\/article\/doi\/10.1093\/biomethods\/bpaf001\/7944099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,9]]}},"URL":"https:\/\/doi.org\/10.1093\/biomethods\/bpaf001","relation":{},"ISSN":["2396-8923"],"issn-type":[{"value":"2396-8923","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"bpaf001"}}